Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.17 (
PCE
)
1,301
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study was carried out to compare the neurobehavioural profile of acute and subchronic tetrachloroethylene (perchloroethylene,
PCE
) exposure in rats. In the acute study, a single bolus of 50 and 500 mg/kg of
PCE
in corn oil was administered by gavage. In the subchronic experiments, rats were exposed to
PCE
at a dosage of 5 and 50 mg/kg in corn oil, 5 days per week for 8 weeks. Nociception, locomotion and seizure susceptibility was tested using open-field, tail immersion and hot plate and pentylenetetrazol-induced seizures, respectively. Subchronic
PCE
exposure exhibited higher antinociceptive effect and lower motor activity in comparison with acute exposure. Pentylenetetrazol-induced convulsion thresholds were elevated following acute
PCE
exposure. In contrast, subchronic
PCE
exposure only increased thresholds for myoclonic twitch and face and forelimb
clonus
without altering the thresholds for running and bouncing
clonus
and tonic hindlimb extension. These findings suggest that subchronic
PCE
exposure results in progressively greater toxic effects on nociception and locomotor activity. The differential effects on seizure susceptibility between acute and subchronic exposure may represent different alterations on neural circuits involved in seizure generation.
...
PMID:Behavioural effects of tetrachloroethylene exposure in rats: acute and subchronic studies. 1178 57